Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9670
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAslan, O.-
dc.contributor.authorYaylalı, Yalın Tolga-
dc.contributor.authorYildirim, S.-
dc.contributor.authorYurtdas, M.-
dc.contributor.authorŞenol, Hande-
dc.contributor.authorUgur-Yildiz, M.-
dc.contributor.authorOzdemir, M.-
dc.date.accessioned2019-08-16T13:04:09Z
dc.date.available2019-08-16T13:04:09Z
dc.date.issued2016-
dc.identifier.issn1076-0296-
dc.identifier.urihttps://hdl.handle.net/11499/9670-
dc.identifier.urihttps://doi.org/10.1177/1076029614546327-
dc.description.abstractSafety issues have been raised about dabigatran. We aimed to investigate the occurrence of safety outcomes in patients who had atrial fibrillation and a risk of stroke. We analyzed 439 patients prescribed dabigatran (n = 220) or warfarin (n = 219). Ischemic stroke occurred in 15 (6.8%) patients in the warfarin group versus 5 (5.2%) patients in the 110-mg group versus 1 (0.8%) patient in the 150-mg dabigatran group (P =.015). Intracranial hemorrhage occurred in 6 (2.7%) patients in the warfarin group versus 3 (2.4%) patients in the 150-mg dabigatran group (P =.104). Death from any cause occurred in 10 (4.6%) patients in the warfarin group versus 1 (1.0%) patient in the 110-mg dabigatran group (P =.005). Dabigatran was associated with less ischemic stroke and death from any cause than warfarin. Dabigatran may be a better option for stroke prophylaxis, where recommended monitoring with warfarin is suboptimal. © SAGE Publications.en_US
dc.language.isoenen_US
dc.publisherSAGE Publications Inc.en_US
dc.relation.ispartofClinical and Applied Thrombosis/Hemostasisen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectdrug monitoringen_US
dc.subjecthemorrhageen_US
dc.subjectmyocardial infarctionen_US
dc.subjectstrokeen_US
dc.subjectthromboembolismen_US
dc.subjectdabigatranen_US
dc.subjectwarfarinen_US
dc.subjectadulten_US
dc.subjectageden_US
dc.subjectarthralgiaen_US
dc.subjectArticleen_US
dc.subjectatrial fibrillationen_US
dc.subjectbrain hemorrhageen_US
dc.subjectbrain ischemiaen_US
dc.subjectcerebrovascular accidenten_US
dc.subjectdizzinessen_US
dc.subjectdrug dose comparisonen_US
dc.subjectdrug safetyen_US
dc.subjectdyspepsiaen_US
dc.subjectdyspneaen_US
dc.subjectfemaleen_US
dc.subjectfluid retentionen_US
dc.subjectheadacheen_US
dc.subjectheart infarctionen_US
dc.subjecthumanen_US
dc.subjectinsomniaen_US
dc.subjectlung embolismen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectnausea and vomitingen_US
dc.subjectpriority journalen_US
dc.subjectrashen_US
dc.subjectretrospective studyen_US
dc.subjectside effecten_US
dc.subjecttreatment outcomeen_US
dc.subjectTurkey (republic)en_US
dc.subjecturinary dysfunctionen_US
dc.subjectvisual disorderen_US
dc.subjectweight gainen_US
dc.subjectweight reductionen_US
dc.subjectchemically induceden_US
dc.subjectclinical trialen_US
dc.subjectcomparative studyen_US
dc.subjectmiddle ageden_US
dc.subjectmulticenter studyen_US
dc.subjectStrokeen_US
dc.subjectTurkeyen_US
dc.subjectvery elderlyen_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectAged, 80 and overen_US
dc.subjectAtrial Fibrillationen_US
dc.subjectBrain Ischemiaen_US
dc.subjectDabigatranen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectWarfarinen_US
dc.titleDabigatran versus warfarin in atrial fibrillation: Multicenter experience in Turkeyen_US
dc.typeArticleen_US
dc.identifier.volume22en_US
dc.identifier.issue2en_US
dc.identifier.startpage147
dc.identifier.startpage147en_US
dc.identifier.endpage152en_US
dc.identifier.doi10.1177/1076029614546327-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid25115764en_US
dc.identifier.scopus2-s2.0-84957710536en_US
dc.identifier.wosWOS:000370068600005en_US
dc.identifier.scopusqualityQ2-
dc.ownerPamukkale University-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.03. Basic Medical Sciences-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

10
checked on Sep 30, 2024

WEB OF SCIENCETM
Citations

10
checked on Sep 16, 2024

Page view(s)

54
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.